mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.008 |
0.9 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.006 |
0.9 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.0083 |
0.9 |